Total Payments
$4,000
2020 Payments
$13.85
Companies
24
Transactions
209
Medicare Patients
266
Medicare Billing
$15,278
Payment Breakdown by Category
Food & Beverage$3,928 (98.2%)
Education$71.50 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,928 | 205 | 98.2% |
| Education | $71.50 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,091 | 35 | $0 (2018) |
| GlaxoSmithKline, LLC. | $655.07 | 35 | $0 (2018) |
| Allergan, Inc. | $396.55 | 22 | $0 (2020) |
| PFIZER INC. | $336.35 | 20 | $0 (2018) |
| Amgen Inc. | $269.65 | 18 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $227.29 | 20 | $0 (2018) |
| Novo Nordisk Inc | $159.32 | 15 | $0 (2018) |
| Amarin Pharma Inc. | $140.33 | 5 | $0 (2017) |
| Lilly USA, LLC | $121.96 | 3 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $108.52 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $13.85 | 1 | Allergan, Inc. ($13.85) |
| 2019 | $27.14 | 1 | Boston Scientific Corporation ($27.14) |
| 2018 | $679.58 | 40 | AstraZeneca Pharmaceuticals LP ($140.53) |
| 2017 | $3,279 | 167 | AstraZeneca Pharmaceuticals LP ($950.84) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/25/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/02/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $97.35 | General |
| Category: Diabetes | ||||||
| 03/30/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Gout/Rheumatology | ||||||
| 03/20/2018 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Respiratory | ||||||
| 03/20/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), INCRUSE | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: RESPIRATORY | ||||||
| 03/19/2018 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2018 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Allergy/Immunology | ||||||
| 03/14/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiology | ||||||
| 03/08/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2018 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Respiratory | ||||||
| 03/02/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), INCRUSE | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Respiratory | ||||||
| 02/22/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology | ||||||
| 02/21/2018 | PFIZER INC. | TOVIAZ (Drug), LYRICA | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 02/19/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
| 02/16/2018 | Ironwood Pharmaceuticals, Inc | DUZALLO (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Rheumatology | ||||||
| 02/15/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 24 | $6,509 | $1,126 |
| 2022 | 4 | 104 | 105 | $26,751 | $5,005 |
| 2021 | 3 | 138 | 142 | $30,910 | $9,147 |
Total Patients
266
Total Services
271
Medicare Billing
$15,278
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 11 | $3,259 | $792.22 | 24.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $3,250 | $334.01 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 46 | $10,660 | $2,120 | 19.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 25 | 25 | $6,250 | $1,287 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,772 | $1,082 | 28.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 17 | 17 | $6,069 | $515.75 | 8.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 78 | $16,630 | $4,674 | 28.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $10,850 | $3,158 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 14 | $3,430 | $1,316 | 38.4% |
About Dr. Shelby Kiles, M.D
Dr. Shelby Kiles, M.D is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2012. The National Provider Identifier (NPI) number assigned to this provider is 1265793426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shelby Kiles, M.D has received a total of $4,000 in payments from pharmaceutical and medical device companies, with $13.85 received in 2020. These payments were reported across 209 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,928).
As a Medicare-enrolled provider, Kiles has provided services to 266 Medicare beneficiaries, totaling 271 services with total Medicare billing of $15,278. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Houston, TX
- Active Since 06/05/2012
- Last Updated 02/15/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265793426
Products in Payments
- FARXIGA (Drug) $561.02
- BREO (Drug) $302.79
- Prolia (Biological) $227.72
- BEVESPI AEROSPHERE (Drug) $207.26
- BYDUREON (Drug) $200.12
- INCRUSE (Drug) $164.39
- CHANTIX (Drug) $159.57
- NAMENDA XR (Drug) $143.45
- ANORO (Drug) $142.37
- Vascepa (Drug) $140.33
- VRAYLAR (Drug) $132.61
- TRULICITY (Drug) $109.19
- EUCRISA (Drug) $100.99
- JARDIANCE (Drug) $95.39
- SYMBICORT (Drug) $91.98
- Saxenda (Drug) $83.44
- SOLIQUA (Drug) $68.04
- Victoza (Drug) $66.98
- XIFAXAN (Drug) $65.82
- Kristalose 20gm (Drug) $57.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Family Medicine $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Family Medicine $158,026
Candice Winful, M.d, M.D
Family Medicine — Payments: $123,290
Family Medicine $123,290
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Family Medicine $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Family Medicine $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226
Family Medicine $78,226